Amyloidosis is the extracellular deposition of amyloid substance having specific structure. Localized respiratory form of amyloidosis is extremely rare, particularly tracheobronchial site [1] [2] .

Amyloidosis is not often taken into consideration in the differential diagnosis of patients with respiratory symptoms.

No clinical, biological and radiological feature is specific of the tracheobronchial localization [1] -[3] .

Histological examination of a biopsy specimen guided by bronchoscopy confirms the diagnosis.

The immunohistochemical analysis allows for the typing of amyloidosis (AA, AL, ...) [1] [2] .

The aim of this work is to review the scarcity of tracheobronchial amyloidosis, the diagnostic difficulty and the need for further monitoring because of the risk of transition to the systemic form and occurrence of life-threatening complications.

A 68-year-old man, with a history of a large smoking, had consulted for a low abundance hemoptysis.

The physical examination was without abnormalities particularly cardiac and pulmonary auscultation as well as neurological and abdominal examinations.

Biological investigations did not reveal anemia or inflammatory syndrome. The white blood cells count, the platelets count and the hemostasis tests were normal. The proteinuria was negative.

The chest radiograph was without anomalies.

Chest CT scan objectified thickening of the walls of the trachea with a moderate luminal narrowing and bronchi which are the seat of calcifications. Neither lymph node enlargement nor pleural effusion was found.

Bronchoscopy found a burgeoning infiltrative lesion training the right side face of the trachea and the anterior edge of the hull.

The hitological examination of tracheobronchial biopsy found an amyloidosis. Typing of this amyloidosis concluded to AL form.

The patient had no other visceral localization of amyloidosis implicating heart, kidney, bvgusalivary glands and bone marrow.

Immunoelectrophoresis of proteins in the blood and urine was normal.

The patient was sent to receive external beam radiation to prepare for endoscopic surgical removal.

Post-operative suites were marked by a complete resolution of clinical signs particularly hemoptysis with a follow-up of two years.

The tracheobronchial amyloidosis is rare; about a hundred cases have been reported in the literature [2] -[4] . This is a localized form of amyloidosis [2] [3] . The most common amyloid pulmonary manifestations are tracheobronchial, nodular, and diffuse interstitial infiltrations.

It is usually symptomatically mimicking at many points bronchial neoplasia particularly when it occurs in a large smoking patient. It most frequently presents by coughing, wheezing, hemoptysis, or unexplained and recurrent pneumopathy [2] -[4] .

The diagnosis is oriented by chest CT and confirmed by biopsy during bronchoscopy [2] -[5] .

Neither chest CT results nor macroscopic aspects at bronchoscopy show specific signs.

The thickening aspect of the tracheal walls revealed in our case can be encountered in many diagnoses as carcinoma, lymphoma and sarcoidosis.

The clinical, radiological and endoscopic feature isn’t contributive for diagnosis confirmation.

Only histological results showing amyloid deposits in the biopsied tissues allow confirming the diagnosis. Specific colorations are recommended to avoid missing the diagnosis.

Solitary nodules or elongated airway narrowing may be mistaken for neoplasia [6] .

After confirming the diagnosis, investigations guided by the symptoms are necessary in search of systemic amyloidosis; cardiac and renal ultrasound evaluations are required to evaluate the patient prognosis [2] . Sometimes, many latent amyloid localizations can be revealed in the occasion of systematic research of other systemic involvement

In our case, tracheo-bronchial amyloidosis was isolated.

A bone marrow aspirate, Immunoelectrophoresis of proteins in the blood and urine are essential, in search of multiple myeloma.

Annual monitoring during the first ten years is essential since there’s a possibility of conversion into systemic disease whose treatment differs from the localized form, almost progression to severe and permanent respiratory impairment and metastatic transformation may occur [6] .

Rare similar cases to our patient were reported in the literature.

Brill AK et al. reported the case of a 65-year-old woman presenting recurrent bronchopulmonary infections, permanent cough and progressive dyspnea. The diagnosis of tracheobronchial amyloidosis was made by histological findings [6] .

Yap JC presented a case of isolated tracheobronchial amyloidosis in a 72-year-old woman complaining of recurrent cough, dyspnoea, haemoptysis and respiratory infection. She received laser therapy with a good evolution [7] .

The treatment of the localized tracheobronchial form is symptomatic.

The treatments offered in the localized tracheobronchial amyloidosis include external beam radiation, endoscopic procedures, debridement, removal and laser [6] [7] .

Elongated stenosis can be managed by laser therapy, balloon dilatation or stenting.

Surgical treatment is rarely indicated. In case of localized AL (amyloid light chain) radiotherapy can be proposed in AL form [6] .

Spontaneous regression has also been noted [8] .

Bronchoscopic procedures and slow progression of this localized amyloidosis allow prognosis improvement. The prognosis is rarely worsened by the evolution to respiratory failure [2] -[4] [6] [8] .

Localized amyloidosis such as tracheobronchial location, is rare and may be the first sign of a systemic disease, the pathogenesis remains unclear. Possible respiratory and systemic complications indicate a regular and prolonged surveillance.

The authors have nothing to disclose.

MadihaMahfoudhi,ImenGorsane,SamiTurki,Taieb BenAbdallah, (2015) Isolated Tracheobronchial Amyloidosis. International Journal of Clinical Medicine,06,643-645. doi: 10.4236/ijcm.2015.69085